Subependymal giant cell tumors in tuberous sclerosis complex

Neurology

Volumn 63, Issue 8, 2004, Pages 1457-1461

  Goh, Suzanne ^a   Butler, William ^a   Thiele, Elizabeth A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN SURGERY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GIANT CELL TUMOR; HUMAN; HYDROCEPHALUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; PRIORITY JOURNAL; PROGNOSIS; SUBEPENDYMOMA; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; TUMOR CLASSIFICATION;

EID: 7044245656     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000142039.14522.1A     Document Type: Article

References (26)

1. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann NY Acad Sci 1991;615:125-127.
2. Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991;66:792-796.
3. Torres OA, Roach ES, Delgado MR, et al. Early diagnosis of subependymal giant cell tumor in patients with tuberous sclerosis. J Child Neurol 1998;13:173-177.
4. Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C. Early diagnosis of subependymal giant cell tumor in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 1999;66:370-375.
5. Cuccia V, Zuccaro G, Sosa F, Monges J, Lubienieky F, Taratuto A. Subependymal giant cell tumor in children with tuberous sclerosis. Childs Nerv Syst 2003;19:232-243.
6. Shepherd CW, Scheithauer BW, Gomez MR, Altermatt HJ, Katzmann JA. Subependymal giant cell tumor: a clinical, pathological, and flow cytometric study. Neurosurg 1991;28:864-868.
7. Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 1996;38:146-155.
8. Menor F, Martí-Bonmatí L, Mulas F, Poyatos C, Cortina H. Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients. Pediatr Radiol 1992;22:485-489.
9. Altman NR, Purser RK, Post M. Tuberous sclerosis: characteristics on CT and MR imaging. Radiology 1988;167:527-532.
10. Roszkowski M, Drabik K, Barszcz S, Jozwiak S. Surgical treatment of intraventricular tumors associated with tuberous sclerosis. Childs Nerv Syst 1995;11:335-339.
11. Braffman BH, Bilaniuk LT, Naidich TP, et al. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology 1992;183:227-238.
12. Scheithauer BW, Reagan TJ. Neuropathology. In: Gomez MR, Sampson JR, Whittemore VH, eds. Tuberous sclerosis complex: developmental perspectives in psychiatry, 3rd ed. New York: Oxford University Press, 1999;101-144.
13. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628.
14. Di Rocco C, Iannelli A, Marchese E. Tuberous sclerosis: neuropsychological implications. Minerva Pediatr 1995;47:111-117.
15. Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16pl3 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 1995;13:295-298.
16. Carbonara C, Longa L, Grosso E, et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 1994;3:1829-1832.
17. Han S, Santos TM, Puga A, et al. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Cancer Res 2004;64:812-816.
18. Harding BN. Malformations of the nervous system. In: Hume LA, Duchen LW, eds. Greenfields neuropathology. London: Edward Arnold, 1992;521-638.
19. Bigner DD, McLendon RE, Bruner JM. Subependymal giant cell astrocytomas. In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein's pathology of tumors of the nervous system, 6th ed. New York: Oxford University Press, 1998;353-356.
20. Ironside JW, Moss TH, Louis DN, Lowe JS, Weller RO. Diagnostic pathology of nervous system tumours. New York: Churchill Livingstone, 2002;67-69.
21. Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999;53:1384-1390.
22. Griffiths PD, Martland TR. Tuberous sclerosis complex: the role of neuroradiology. Neuropediatrics 1997;28:244-252.
23. Kim SK, Wang KC, Cho BK, et al. Biological behavior and tumorigenesis of subependymal giant cell astrocytomas. J Neurooncol 2001;52:217-225.
24. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
25. Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64:1305-1315.
26. Hyman MH, Whittemore VH. National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 2000;57:662-665.